Navigation Links
Hospitalization Rates for Coronary Artery Disease Decline in the,U.S.

64,000 to 592,000.

"Our study shows a decline in utilization for inpatient services related to coronary artery disease, possibly reflecting a distinct shift in the nature of treatment," said Brahmajee Nallamothu, M.D., assistant professor of internal medicine at the University of Michigan Medical School and health services researcher at the Ann Arbor Veterans Administration Medical Center. "There is reason to believe this landscape will continue to change. Recent research, for example, raises questions about the use of drugs, stents, and surgery under various scenarios. Clearly, healthcare providers need to evaluate the needs of their specific patient populations in light of the most current research as they plan and prepare for the future."

The researchers used Solucient's ACTracker(R) database, a proprietary repository containing data on approximately 6 million annual discharges from more than 450 hospitals.

About The Thomson Corporation and Solucient

Solucient(R), a part of Thomson Healthcare, is the market leader in providing tools and vital insights that healthcare managers use to improve the performance of their organizations. By integrating, standardizing and enhancing healthcare information, Solucient provides comparative measurements of cost, quality and market performance. Solucient's expertise and proven solutions enable providers and pharmaceutical companies to drive business growth, manage costs and deliver high quality care. For more information, visit www.thomsonhealthcare.com.

The Thomson Corporation (www.thomson.com) is a global leader in providing essential electronic workflow solutions to business and professional customers. With operational headquarters in Stamford, Conn., Thomson provides value-added information, software tools and appli
'"/>




Page: 1 2 3

Related medicine technology :

1. Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death
2. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
3. Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
4. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
5. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
6. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
7. Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term Safety Study of Lialda (mesalamine) Presented at DDW
8. New Study Demonstrates that Lubiprostone May Improve Symptom Relief Rates in Adults with Irritable Bowel Syndrome with Constipation (IBS-C)
9. Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma
10. Preterm Infants with Respiratory Distress Syndrome: Incidence Rates of Death when Treated with Surfactant Replacement Therapies
11. Over 10,000 UK Breast Cancer Patients Could Become Eligible Within the Next Year for a Breast Cancer Therapy Showing Increased Survival Rates, Reveals Synovate Healthcare’s European Oncology Monitor
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Hospitalization Rates for Coronary Artery Disease Decline the
(Date:12/16/2009)... Dec. 16 According to Millennium Research ... market intelligence, although the US minimally invasive spinal ... growth rate of over 12% through 2014, reimbursement ... the overall market, which previously had been forecast ... for Minimally Invasive Spine Technologies 2010 ...
(Date:12/16/2009)... HDT Engineered Technologies (HDT), a leader ... a principal subcontractor for the mechanical development of ... new anthropromorphic arm technology that will give patients ... hand, including a sense of touch. ,, ... Agency (DARPA) Revolutionizing Prosthetics 2009 (RP2009) project, the ...
(Date:12/16/2009)... Accuray Incorporated (Nasdaq: ARAY ), a global leader ... president and chief executive officer, Euan S. Thomson, Ph.D., ... Morgan Healthcare Conference in San Francisco on Wednesday, January ... ,, A live webcast of each presentation will be ... Company,s Web site at http://www.accuray.com . The ...
Breaking Medicine Technology:Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking 2Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking 3HDT Develops Robotic Arm Technology for DARPA's Revolutionizing Prosthetics 2009 Program 2Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference 2Vivakor Announces Additions to Board of Directors and Scientific Advisory Board 15083 1Vivakor Announces Additions to Board of Directors and Scientific Advisory Board 15083 2Vivakor Announces Additions to Board of Directors and Scientific Advisory Board 15083 3Despite Limited Capital Equipment Purchases In 2009 The Global Powered Surgical Instrument Market Held Its Value At 24800 Million 6792 1Despite Limited Capital Equipment Purchases In 2009 The Global Powered Surgical Instrument Market Held Its Value At 24800 Million 6792 2Despite Limited Capital Equipment Purchases In 2009 The Global Powered Surgical Instrument Market Held Its Value At 24800 Million 6792 3VidaySalud com 28TM 29 Reaches 1 000 000 Page Views In its First Six Months of Operation 6788 1VidaySalud com 28TM 29 Reaches 1 000 000 Page Views In its First Six Months of Operation 6788 2
... Follow-up RAS data presented at ASCO , HORSOLM, ... presentation titled "RAS peptide vaccination in resected,pancreatic cancer ... term survival" at ASCO's (American Society of Clinical,Oncology) ... 23 resected pancreatic cancer patients,immunized in the period ...
... Positive data on subcutaneous administration show potential for,new ... June 04, 2007 /PRNewswire-FirstCall/ -- Millennium,Pharmaceuticals, Inc. today ... market-leading therapy for patients with,multiple myeloma (MM) who ... include results from a Phase II trial for ...
Other Medicine Technology:Pharmexa A/S (DK) - Long lasting immune response and survival to,RAS vaccine 2New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 2New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 3New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 4New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 5New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 6New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 7
(Date:12/17/2009)... the last few weeks there has been an increase ... by e cigarette opposition in an attempt to scare ... the tactics of these groups when the evidence clearly ... to tobacco according to several studies, lab reports and ... the world. ,, Special interest groups appear to ...
(Date:12/17/2009)... Dec. 17 John Howell, CEO ... of Arrayit Corporation (OTC Bulletin Board: ARYC), ... for commercialization of its microarray-based OvaDx(TM) ... is currently advancing through late-stage development - ... exclusively to the Company by Arrayit Corporation. ...
(Date:12/17/2009)... revealing portrait of the nearly one-in-three American adults who serve as ... ... 17, 2009 -- The National Alliance on Mental Illness (NAMI) praises ... offers a revealing portrait of the nearly one-in-three American adults who ... on interviews with 1,480 caregivers chosen at random and offers a ...
(Date:12/17/2009)... search engines like Google Local and in front of their local ... Local Registration service offered by New Orleans based Webtyde Internet Marketing. ... ... -- In order to be competitive locally and nationally, businesses must ... a local map section in a major search engine, a business ...
(Date:12/17/2009)... marketing techniques, life coaching company puts free i-phone & ... http://itunes.apple.com/us/app/attainment-life-management/id345691804?mt=8 . For the Free download. , ... ... -- Utah based Attainment Life Management & Coaching is ... everything in life simplified into one little hand held ...
Breaking Medicine News(10 mins):Health News:Special Interest Deceptions Continue to Rampant About Electronic Cigarettes 2Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 2Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 3Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 4Health News:NAMI Applauds New Report on Caregiving 2Health News:NAMI Applauds New Report on Caregiving 3Health News:New Orleans Based Internet Marketing Is Helping Small Businesses Get a Chance to Shine On the Web 2Health News:Attainment Life Management & Coaching has just Debuted its Free Application for I-Phone and I-Touch Users 2
... Gorakhpur District are grappling to fight against a deadly viral ... children in the past five months. ,Dr. A.K.Rathi, Head ... run by the college has received over 100 patients since ... of the disease. ,Dr. M.P.Singh, Joint-Director ...
... The battle against HIV/AIDS is becoming grimmer by the day. ... could be infected with HIV/AIDS by 2015 if the ... ,"We should be winning in HIV prevention," Jennifer Kates, ... Family Foundation, said Friday. ,But the reality is ...
... rashes. Prescription medications including steroid creams that ease ... ,When over five million Americans suffer from that skin ... response, especially when backed by some kind of evidence.,And ... though experts are skeptical. ,"We can control ...
... turning its excess wine produce into bioethanol. ... ,Commission officials have, however, made it clear ... subsidize such a move. ,Michael Mann, commission spokesman ... to do would be to stop the excess wine from ...
... a growing segment of the population but vote less ... favor Democrats over Republicans, said a study published Friday. ... older now account for 45.2 percent of the US ... Vote said in its study titled "Unmarried America 2007: ...
... that women with at least three sites of cellular atypia ... than average women to develop breast cancer. , ... atypia) in breast tissue is a major risk factor for ... diagnosed with atypia are considered at high risk. ...
Other Medicine News:Health News:Expand HIV/AIDS Prevention Programs, Experts Stress 2Health News:Expand HIV/AIDS Prevention Programs, Experts Stress 3Health News:Experts Critical of a New OTC Product to Treat Psoriasis 2Health News:Experts Critical of a New OTC Product to Treat Psoriasis 3Health News:Single Americans Vote Less, but Lean Towards Democrats: Study 2Health News:Women With Atypia Nearly Eight Times More Likely to Develop Breast Cancer 2
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
... and exchange in endourological procedures. The increased ... allows utilization of an extra heavy duty ... very flexible tip. The proximal end of ... coiled wire guide manufactured by Cook®. Supplied ...
Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: